Hepatocellular carcinoma: a review

J Balogh, D Victor III, EH Asham… - Journal of …, 2016 - Taylor & Francis
Hepatocellular carcinoma (HCC) is the most common primary liver malignancy and is a
leading cause of cancer-related death worldwide. In the United States, HCC is the ninth …

Treatment of intermediate-stage hepatocellular carcinoma

A Forner, M Gilabert, J Bruix, JL Raoul - Nature reviews Clinical …, 2014 - nature.com
Hepatocellular carcinoma (HCC)—closely associated with liver cirrhosis and, in fact, the
main cause of death in patients with such disease—is now recognized as one of the most …

EASL–EORTC clinical practice guidelines: management of hepatocellular carcinoma

European Association For The Study Of … - Journal of …, 2012 - journal-of-hepatology.eu
EASL–EORTC Clinical Practice Guidelines (CPG) on the management of hepatocellular
carcinoma (HCC) define the use of surveillance, diagnosis, and therapeutic strategies …

[HTML][HTML] EASL–EORTC clinical practice guidelines: management of hepatocellular carcinoma

EO for Research… - Journal of …, 2012 - Elsevier
EASL–EORTC Clinical Practice Guidelines (CPG) on the management of hepatocellular
carcinoma (HCC) define the use of surveillance, diagnosis, and therapeutic strategies …

Radioembolization for hepatocellular carcinoma using Yttrium-90 microspheres: a comprehensive report of long-term outcomes

R Salem, RJ Lewandowski, MF Mulcahy, A Riaz… - Gastroenterology, 2010 - Elsevier
BACKGROUND & AIMS: Hepatocellular carcinoma (HCC) has limited treatment options;
long-term outcomes following intra-arterial radiation are unknown. We assessed clinical …

Radioembolization results in longer time-to-progression and reduced toxicity compared with chemoembolization in patients with hepatocellular carcinoma

R Salem, RJ Lewandowski, L Kulik, E Wang, A Riaz… - Gastroenterology, 2011 - Elsevier
BACKGROUND & AIMS: Chemoembolization is one of several standards of care treatment
for hepatocellular carcinoma (HCC). Radioembolization with Yttrium-90 microspheres is a …

[PDF][PDF] Loco‐regional treatment of hepatocellular carcinoma

R Lencioni - Hepatology, 2010 - Wiley Online Library
Loco‐regional treatments play a key role in the management of hepatocellular carcinoma
(HCC). Image‐guided tumor ablation is recommended in patients with early‐stage HCC …

Correlation of Y90-absorbed radiation dose to pathological necrosis in hepatocellular carcinoma: confirmatory multicenter analysis in 45 explants

A Gabr, A Riaz, GE Johnson, E Kim, S Padia… - European Journal of …, 2021 - Springer
Purpose To study the correlation between absorbed perfused liver dose using Y90
radioembolization and degree of hepatocellular carcinoma (HCC) necrosis in liver explants …

[PDF][PDF] Unresectable solitary hepatocellular carcinoma not amenable to radiofrequency ablation: multicenter radiology‐pathology correlation and survival of radiation …

M Vouche, A Habib, TJ Ward, E Kim, L Kulik… - …, 2014 - Wiley Online Library
Resection and radiofrequency ablation (RFA) are treatment options for hepatocellular
carcinoma (HCC)< 3 cm; there is interest in expanding the role of ablation to 3‐5 cm. RFA is …

[HTML][HTML] Radioembolization for hepatocellular carcinoma

B Sangro, M Iñarrairaegui, JI Bilbao - Journal of hepatology, 2012 - Elsevier
Radioembolization is a form of brachytherapy in which intra-arterially injected 90Y-loaded
microspheres serve as sources for internal radiation purposes. It produces average disease …